Aptevo Therapeutics Inc. buy me8
Start price
12.12.22
/
0%
€5.39
Target price
12.12.23
€7.00
Performance (%)
-60.16%
End price
24.12.22
€2.15
Summary
This prediction ended on 24.12.22 with a price of €2.15. The BUY prediction by me8 for Aptevo Therapeutics Inc. performed very badly with a performance of -60.16%. This prediction was marked as speculative and is excluded from me8's performance statistics.Unfortunately, there is no listed company called Aptevo Therapeutics with the symbol APVOV. However, there is a company with the symbol APVO. Aptevo Therapeutics is a biotechnology company that focuses on the discovery, development, and commercialization of novel oncology and hematology therapeutics. The company's product portfolio includes treatments for a variety of conditions such as hemophilia, immune disorders, and cancer. Their approach involves using genetically engineered proteins to target specific diseases and their therapies have shown promising results in clinical trials.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Aptevo Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -0.922% | -1.078% | 12.165% |
| iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% |
| iShares Nikkei 225® | 2.224% | -2.825% | 19.015% |
| iShares S&P 500 | -0.026% | -0.788% | 28.485% |
According to me8 what are the pros and cons of Aptevo Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
Cons
Little innovation
Comments by me8 for this prediction
In the thread Aptevo Therapeutics Inc diskutieren
Buy Aptevo Therapeutics Inc.
Kursziel gesetzt auf 7,0
In the thread Trading Aptevo Therapeutics Inc.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.